Relapsed/refractory patients

Jesus Berdeja | EHA 2018 | The CRB-401 phase I bb2121 CAR T-cell study

L:

23rd Congress of European Hematology Association, 14-17 June 2018, Stockholm, Sweden

Jesus Berdeja
Sarah Cannon Research Institute, Nashville, US

Interview topic: Summary of results from the CRB-401 phase I bb2121 CAR-T cell study

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF